Literature DB >> 18804269

Immunoglobulin therapy: methods of delivery.

Mark Ballow1.   

Abstract

Mesh:

Substances:

Year:  2008        PMID: 18804269     DOI: 10.1016/j.jaci.2008.08.012

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  10 in total

Review 1.  Periodontal and other oral manifestations of immunodeficiency diseases.

Authors:  M E Peacock; R M Arce; C W Cutler
Journal:  Oral Dis       Date:  2016-10-10       Impact factor: 3.511

2.  Dosing and therapy utilization: a discussion of updates on PI treatment guidelines.

Authors:  Mark Ballow
Journal:  J Clin Immunol       Date:  2012-06-23       Impact factor: 8.317

3.  SCIg vs. IVIg: let's give patients the choice!

Authors:  K Samaan; M C Levasseur; H Decaluwe; C St-Cyr; H Chapdelaine; A Des Roches; E Haddad
Journal:  J Clin Immunol       Date:  2014-06-03       Impact factor: 8.317

Review 4.  Pathogenesis, diagnosis, and management of primary antibody deficiencies and infections.

Authors:  Ari J Fried; Francisco A Bonilla
Journal:  Clin Microbiol Rev       Date:  2009-07       Impact factor: 26.132

Review 5.  Advances in basic and clinical immunology in 2008.

Authors:  Javier Chinen; William T Shearer
Journal:  J Allergy Clin Immunol       Date:  2009-02       Impact factor: 10.793

Review 6.  Subcutaneous immunoglobulin for primary and secondary immunodeficiencies: an evidence-based review.

Authors:  Jenny Lingman-Framme; Anders Fasth
Journal:  Drugs       Date:  2013-08       Impact factor: 9.546

Review 7.  Historical perspectives in the diagnosis and treatment of primary immune deficiencies.

Authors:  Mark Ballow
Journal:  Clin Rev Allergy Immunol       Date:  2014-04       Impact factor: 8.667

Review 8.  A clinician's guide for administration of high-concentration and facilitated subcutaneous immunoglobulin replacement therapy in patients with primary immunodeficiency diseases.

Authors:  Kristin Epland; Daniel Suez; Kenneth Paris
Journal:  Allergy Asthma Clin Immunol       Date:  2022-09-30       Impact factor: 3.373

Review 9.  Common variable immunodeficiency: an update.

Authors:  Ulrich Salzer; Klaus Warnatz; Hans Hartmut Peter
Journal:  Arthritis Res Ther       Date:  2012-09-24       Impact factor: 5.156

10.  One-year intravenous immunoglobulin replacement therapy: efficacy in reducing hospital admissions in pediatric patients with Inborn Errors of Immunity.

Authors:  Karina Mescouto de Melo; Lucas Macedo Alves; Cláudia França Cavalcante Valente; Fabíola Scancetti Tavares
Journal:  J Pediatr (Rio J)       Date:  2021-07-14       Impact factor: 2.990

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.